| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V75422 | GPR88-IN-1 | 714265-50-6 | GPR88-IN-1 is a GPR88 inhibitor that may be utilized in the research/study of central diseases. |
|
V1804 | GSK1292263 | 1032823-75-8 | GSK1292263 is a novel and potentGPR119 (G-protein-coupled receptor 119) agonist whichhas potential for the treatment of type 2 diabetes. |
|
V1805 | GW9508 | 885101-89-3 | GW9508 is a novel, potent and selective agonist for FFA1 (fatty acid receptor GPR40) with pEC50 of 7.32, and is 100-fold selective against GPR120, it stimulates insulin secretion in a glucose-sensitive manner. |
|
V70560 | hMCH-1R antagonist 1 | 353487-64-6 | hMCH-1R antagonist 1 (Compound 30) is a potent and specific human melanin concentrating hormone receptor 1 (hMCHR1) antagonist (inhibitor) with a KB of 3.6 nM. |
|
V70310 | L-α-lysophosphatidylinositol (Soy) (sodium) | 796963-91-2 | L-α-lysophosphatidylinositol Soy sodium is the endogenous ligand of GPR55. |
|
V75414 | MS48107 | 2375070-79-2 | MS48107 is a potent and specific PAM (positive allosteric modulator) of G protein-coupled receptor 68 (GPR68). |
|
V104751 | Ogerin analogue 1 | 1125453-08-8 | Ogerin analog 1 (compound 20) is a structural analog of ogerin and is usually used as a negative control. |
|
V75417 | Ogremorphin (OGM; GPR68-IN-1) | 352563-21-4 | Ogremorphin (GPR68-IN-1) is a potent GPR68 inhibitor (antagonist) with EC50 of 170 nM. |
|
V70306 | PSN 375963 hydrochloride | 1781834-82-9 | PSN 375963 HCl is a potent GPR119 agonist/activator with EC50 of 8.4 and 7.9 μM in humans and mice, respectively. |
|
V86630 | PW0729 | 2767348-36-5 | PW0729 (compound 15b) is an orphan GPR52 agonist with potential applications in GPR52 activation, signaling bias, and neuropsychiatric and neurological disorders. |
|
V93165 | RTI-122 | 3034664-39-3 | RTI-122 is a potent GPR88 agonist with good metabolic stability (half-life of 5.8 h in mice) and a cAMP EC50 of 11 nM, and is able to cross the blood-brain barrier. |
|
V76546 | RTI-13951-33 hydrochloride | RTI-13951-33 HCl is a specific, BBB (blood-brain barrier) permeable (penetrable) GPR88 agonist/activator with EC50 of 25 nM in GPR88 cAMP functional assays. | |
|
V15926 | TC-H 106 | 937039-45-7 | Pimelic Diphenylamide 106 is a slow, tight-binding class I HDAC inhibitor (inhibits HDAC1, 2, and 3, IC50s 150 nM, 760 nM, and 370 nM, respectively) with no activity against class II HDACs. |
|
V1807 | Timapiprant (OC000459) | 851723-84-7 | Timapiprant (formerly known as OC000459; OC-000459) is a novel, potent, selective, and orally bioactive prostanoid receptor 2 (DP2- also known as CRTH2)) antagonist with IC50 of 13 nM. |
|
V86634 | TUG-2099 | TUG-2099 (compound 4s) is a potent GPR84 agonist with an EC50 of 0.3 nM. | |
|
V86631 | TUG-2208 | TUG-2208 (compound 42a) is a GPR84 agonist (pEC50=8.98) with low lipophilicity, good solubility, in vitro permeability, and microsomal stability. | |
|
V70308 | Zelatriazin (TAK-041; NBI-1065846) | 1929519-13-0 | Zelatriazin (TAK-041; NBI-1065846) is a potent and specific GPR139 agonist/activator with EC50 of 22 nM. |
|
V75419 | ZQ-16 | 376616-73-8 | ZQ-16 is a potent and specific GPR84 agonist/activator with EC50 of 0.213 μM. |
|
V15704 | Latanoprost (PHXA41, XA34) | 130209-82-4 | Latanoprost (PHXA-41, XA-34) is a novel prostaglandinF2α analogue that lowers the pressure by increasing the outflow of aqueous fluid from the eyes through the uvealsclearal tract. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
